# Fengchun Zhang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fengchun-zhang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,504 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 40 |
| i10-index | 96 |
| Last Known Institution | Ministry of Education of the People's Republic of China |
| OpenAlex ID | https://openalex.org/A5100783681 |
| ORCID iD | 0000-0003-3484-4319 |
| Works | 207 |

## Researcher papers

- [Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19](https://scholariq.org/papers/coagulopathy-and-antiphospholipid-antibodies-in-patients-with-covid-19/)
- [A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea](https://scholariq.org/papers/a-pivotal-phase-iii-randomised-placebo-controlled-study-of-belimumab-in-patients/)
- [Clinical characteristics of immunoglobulin G4–related disease: a prospective study of 118 Chinese patients](https://scholariq.org/papers/clinical-characteristics-of-immunoglobulin-g4-related-disease-a-prospective/)
- [Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study](https://scholariq.org/papers/characterizing-igg4-related-disease-with-18f-fdg-pet-ct-a-prospective-cohort/)
- [Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19](https://scholariq.org/papers/antiphospholipid-antibodies-in-critically-ill-patients-with-covid-19/)
- [Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis](https://scholariq.org/papers/metagenomic-profiling-of-the-pro-inflammatory-gut-microbiota-in-ankylosing/)
- [Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms](https://scholariq.org/papers/mesenchymal-stem-cell-treatment-improves-outcome-of-covid-19-patients-via/)
- [Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years](https://scholariq.org/papers/death-causes-and-pathogens-analysis-of-systemic-lupus-erythematosus-during-the/)
- [Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/telitacicept-in-patients-with-active-systemic-lupus-erythematosus-results-of-a/)
- [Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study](https://scholariq.org/papers/early-biochemical-response-to-ursodeoxycholic-acid-and-long-term-prognosis-of/)
- [Treatment of refractory lupus nephritis using leflunomide: A prospective study](https://scholariq.org/papers/treatment-of-refractory-lupus-nephritis-using-leflunomide-a-prospective-study/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [IgG4-Related and Inflammatory Diseases](https://scholariq.org/topics/igg4-related-and-inflammatory-diseases/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Researcher university

- [Ministry of Education of the People's Republic of China](https://scholariq.org/institutions/ministry-of-education-of-the-people-s-republic-of-china/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.